Staphylococcal Enterocolitis—Treatment with Oral Vancomycin

Abstract

Article1 July 1966Staphylococcal Enterocolitis—Treatment with Oral VancomycinMOHAMMED Y. KHAN, M.B., WENDELL H. HALL, M.D., F.A.C.P.MOHAMMED Y. KHAN, M.B., WENDELL H. HALL, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-65-1-1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAn increased prevalence of staphylococcal enterocolitis, arising as a serious complication of antibiotic therapy, has recently been reported in hospital patients. We have observed 109 patients with this disease during the past decade. A brief review of the therapy in these patients is given. Among these 109 patients, 45 were treated orally with vancomycin. A summary of our striking success in the treatment of these patients is presented.MATERIAL AND METHODSThe cases selected for study included all of the 109 patients with staphylococcal enterocolitis observed at the Minneapolis Veterans Administration Hospital between 1955 and 1965.The diagnosis was made...References1. BAUERPERRYKIRBY AWDMWM: Single-disk antibiotic sensitivity testing of staphylococci. Arch. Intern. Med. (Chicago) 104: 208, 1958. CrossrefGoogle Scholar2. WAISBRENCARRDUNETTE BACJ: The tube dilution method of determining bacterial sensitivity to antibiotics. Amer. J. Clin. Path. 21: 884, 1951. CrossrefMedlineGoogle Scholar3. KRAMER IR: Fatal staphylococcal enteritis developing during streptomycin therapy by mouth. Lancet 255: 646, 1948. CrossrefGoogle Scholar4. SPEARE GS: Staphylococcal pseudomembranous enterocolitis, a complication of antibiotic therapy. Amer. J. Surg. 88: 523, 1954. CrossrefMedlineGoogle Scholar5. DEARINGBAGGENSTOSSWEED WHAHLA: Studies on relationship of Staphylococcus aureus to pseudomembranous enterocolitis and to postantibiotic enteritis. Gastroenterology 38: 441, 1960. CrossrefMedlineGoogle Scholar6. TISDALEFENSTERKLATSKIN WALFG: Acute staphylococcal enterocolitis complicating oral neomycin therapy in cirrhosis. New Eng. J. Med. 263: 1014, 1960. CrossrefMedlineGoogle Scholar7. ALTEMEIERHUMMELHILL WARPEO: Staphylococcal enterocolitis following antibiotic therapy. Ann. Surg. 157: 847, 1963. CrossrefMedlineGoogle Scholar8. LAVINEHURSTGROSSMANLEE DVMM: Staphylococcus of a newly recognized bacteriophage type. JAMA 192: 935, 1965. CrossrefMedlineGoogle Scholar9. HUMMELALTEMEIERHILL RPWAEO: Iatrogenic staphylococcal enterocolitis. Ann. Surg. 160: 551, 1964. CrossrefMedlineGoogle Scholar10. FINEGOLDGAYLOR SMDW: Enterocolitis due to phage type 54 staphylococci resistant to kanamycin, neomycin, paramomycin and chloramphenicol. New Eng. J. Med. 263: 1110, 1960. CrossrefMedlineGoogle Scholar11. HINTONTAGGARTORR NAJGJH: The significance of the isolation of coagulase-positive staphylococci from stool. With special reference to the diagnosis of staphylococcal enteritis. Amer. J. Clin. Path. 33: 505, 1960. CrossrefMedlineGoogle Scholar12. WEBSTER CU: Staphylococcal diarrhea. Lancet 2: 1036, 1958. CrossrefMedlineGoogle Scholar13. GERACIHEILMANNICHOLSWELLMANROSS JEFRDRWECT: Some laboratory and clinical experience with a new antibiotic, vancomycin. Mayo Clin. Proc. 31: 564, 1956. MedlineGoogle Scholar14. WOODLEYHALL DWWH: The treatment of severe staphylococcal infection with vancomycin. Ann. Intern. Med. 55: 235, 1961. LinkGoogle Scholar15. WALLACESMITHPETERSDORF JFRHRG: Oral administration of vancomycin in the treatment of staphylococcal enterocolitis. New Eng. J. Med. 272: 1014, 1965. CrossrefMedlineGoogle Scholar16. CLUFFREYNOLDS LERJ: Management of staphylococcal infections. Amer. J. Med. 39: 812, 1965. CrossrefMedlineGoogle Scholar17. GILLHOOK FAEW: Changing pattern of bacterial resistance to antimicrobial drugs. Ibid., p. 781. Google Scholar18. ROSS IP: Acute staphylococcal enterocolitis treated with methicillin. Brit. Med. J. 2: 166, 1962. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Minneapolis, MinnesotaFrom the Medical Service, Veterans Administration Hospital and the University of Minnesota Medical School, Minneapolis, Minn.Requests for reprints should be addressed to Wendell H. Hall, M.D., Veterans Administration Hospital, 48th Ave. and 54th St., Minneapolis, Minn. 55417. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA worldwide systematic review and meta-analysis of bacteria related to antibiotic-associated diarrhea in hospitalized patientsZeolite‐containing mixture alleviates microbial dysbiosis in dextran sodium sulfate‐induced colitis in miceEffective Dosage of Oral Vancomycin in Treatment for Initial Episode of Clostridioides difficile Infection: A Systematic Review and Meta-AnalysisClostridioides difficile therapeutics: guidelines and beyondProton pump inhibitors and risk of Clostridium difficile infectionClostridium difficile in the ICUFecal microbiota transplantation–early steps on a long journey aheadClostridium difficile infection: Evolution, phylogeny and molecular epidemiologyFMT in Clostridium difficile and Other Potential UsesClostridium difficile InfectionVancomycin treatment and butyrate supplementation modulate gut microbe composition and severity of neointimal hyperplasia after arterial injuryPredictive Values of Models of Clostridium difficile InfectionClostridium difficile DiseaseDiagnosis and Management of Clostridium difficile InfectionClostridium difficile infectionBiology of Clostridium difficile : Implications for Epidemiology and DiagnosisAustralasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infectionGenetic Manipulation of Clostridium difficileClostridium difficile and the Disease It CausesAntibiotic-Associated Diarrhea, Pseudomembranous Enterocolitis, and Clostridium difficile-Associated Diarrhea and ColitisClostridium difficile infection: Historic reviewAntibiotic-associated diarrhea due to methicillin-resistant Staphylococcus aureusClostridium difficileThe Case for Vancomycin as the Preferred Drug for Treatment of Clostridium difficile InfectionTreatment of Clostridium Difficile Colitis in the Critical Care SettingHistorical Perspectives on Studies of Clostridium difficile and C. difficile InfectionClostridium difficileNarrative Review: The New Epidemic of Clostridium difficile–Associated Enteric DiseaseJohn G. Bartlett, MDAn Update on Diagnosis, Treatment, and Prevention of Clostridium difficile–Associated DiseaseColitis Due to Clostridium Difficile Toxins: Underdiagnosed, Highly Virulent, and NosocomialAntibiotic-associated colitis—A review of 66 casesTreatment of Clostridium difficile-associated disease: old therapies and new strategiesEffectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unitMethicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocolClostridium difficile-associated enteric diseaseDescontaminación selectiva del tubo digestivo: efecto sobre la incidencia de la infección nosocomial y de los microorganismos multirresistentes en enfermos ingresados en unidades de cuidados intensivosOral Vancomycin in the Control of MRSA Outbreaks in the ICUMultiple intestinal ulcerations and perforations secondary to methicillin-resistant Staphylococcus aureus enteritis in infantsClostridium difficileComparison of four laboratory tests for diagnosis ofClostridium difficile-associated diarrheaReview article: antibiotics and the gutHistorical AspectsAntimicrobial Agent–Associated Diarrhea in Adult HumansPathology and Diagnosis of Clostridium difficile DiseaseClostridium difficile: its disease and toxinsCefazolin-induced pseudomembranous colitis resulting in perforation of the sigmoid colonDouble blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis.Treatment of Clostridium difficile colitisVancomycinPseudomembranous Colitis: Pathogenesis and TherapyAntibiotic‐associated diarrhoea and methicillin‐resistant Staphylococcus aureusMedical Management of Antimicrobial-Associated Diarrhea and ColitisLetter to the editorVancomycin and related antibioticsVancomycinTreatment of Clostridium difficile colitis and diarrhea with vancomycinPseudomembranous (antibiotic-associated) colitisAntibiotika-assoziierte Diarrhoe und EnterocolitisNecrotizing colitis in patients with cancerAntibiotic-associated ColitisORAL VANCOMYCIN FOR ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITISVancomycin RevisitedFRANCIS V. COOK, M.D., W. EDMUND FARRAR Jr., M.D., F.A.C.P.Paradox of antibiotic treatment of antibiotic-associated diarrheaExperimental clindamycin-associated colitis in rabbitsANTIBIOTIC-INDUCED COLITIS IMPLICATION OF A TOXIN NEUTRALISED BY CLOSTRIDIUM SORDELLII ANTITOXINClindamycin-Associated Colitis in Hamsters: Protection with VancomycinInhibition of dental caries in school children by topically applied vancomycinNeonatal staphylococcal enterocolitis: Association with indwelling feeding catheters and S. aureus colonizationVancomycinCephalothin and Cephaloridine Therapy for Bacterial Meningitis An EvaluationLARRY S. FISHER, M.D., ANTHONY W. CHOW, M.D., F.R.C.P.(C), THOMAS T. YOSHIKAWA, M.D., LUCIEN B. GUZE, M.D., F.A.C.P.A Review of Vancomycin: After 15 Years of UseInfektionen des IntestinaltraktesManagement of Excess Serum LipidStaphylococcal infections—Treatment and controlInfectious diseases. Annual review of significant publications 1 July 1966Volume 65, Issue 1Page: 1-8KeywordsAntibioticsChloramphenicolCirrhosisComaDiarrheaEnterocolitisMedical servicesPatientsRisk managementVancomycin ePublished: 1 December 2008 Issue Published: 1 July 1966 Copyright & PermissionsCopyright ©, 1966, by The American College of PhysiciansPDF downloadLoading ...